Relmada Therapeutics, Inc. (RLMD)

7.04 -0.17 (-2.36%) USD  |  NASDAQ  |  May 22, 16:00
7.05 +0.01 (+0.14%) After-Hours: 20:00
More

Relmada Therapeutics EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Theravance Biopharma, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade